Browse by Speaker

Home
Browse by Speaker

Browse by Speaker

Type here to filter the list

V
Vabre, Clémentine

Heva

3C-05 - Impact of the lookback period, age and gender on the estimation of the incidence of diabetes and heart failure on medico-administrative databases – FIREFLY study
Location: 201

Clémentine Vabre

Favorite

Vaidya, Avi

Vanderbilt University Medical Center

6D-06 - Inequities in the Use of Orally-administered Antimyeloma Therapies Granted Accelerated Approval
Location: 201

Avi Vaidya

Favorite

Valko, Matthew

Boehringer Ingelheim Pharmaceuticals Inc,

2E-06 - Impacts of RWD-related biases in Bayesian borrowing through the use of simulation study
Location: 202AB

Matthew Valko

Favorite

Vallejo-Yagüe, Enriqueta

Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland

SC-14 - Emerging Topic: How to StudyHealth Disparities in Pharmacoepidemiology- An introduction to fundamentals and methods
Location: Ballroom AB

Enriqueta Vallejo-Yagüe

Favorite

SW-4G - Seeking the roadmap: Incorporating menstruation and menopause into pharmacoepidemiology research
Location: 201

Enriqueta Vallejo-Yagüe

Favorite

van Gelder, Marleen

IQ Health science department, Radboud university medical center, Nijmegen, The Netherlands

2G-03 - Paternal exposure to valproate and risk of neurodevelopmental disorders in children – a nationwide registry-based study in Norway
Location: 208AB

Marleen van Gelder

Favorite

SW-4G - Seeking the roadmap: Incorporating menstruation and menopause into pharmacoepidemiology research
Location: 201

Marleen van Gelder

Favorite

Van Rompay, Maria

Carelon Research

6D-02 - Developing a Cancer Stage Model in Patients with Incident Colorectal Cancer Using Data from a Cancer Care Quality Program and Administrative Claims
Location: 201

Maria Van Rompay

Favorite

van Willigen, Marcel

Julius Clinical

5C-01 - Monitoring the Safety of mRNA-1273 COVID-19 Vaccine in the General Population: Results of a Regulator-mandated Post-authorisation Safety Study in Denmark, Norway, Spain, and the United Kingdom (EUPAS44273).
Location: 204ABC

Marcel van Willigen

Favorite

Vasilakis-Scaramozza, Catherine

Boston Collaborative Drug Surveillance Program

3B-02 - Risk of Incident Atrial Fibrillation among Female Users of Osteoporosis Treatments
Location: 204ABC

Catherine Vasilakis-Scaramozza

Favorite

Vasilopoulos, Athan

AbbVie

6D-03 - Epidemiology of MET gene mRNA expression in metastatic colorectal cancer: analyses of a real-world clinicogenomic database
Location: 201

Athan Vasilopoulos

Favorite

Vazquez Benitez, Gabriela

Pregnancy and Child Health Research Center, HealthPartners Institute

6B-03 - Linkage of Electronic Health Record Data Across Two Healthcare Systems for Perinatal Health Research: A Privacy-Preserving Approach
Location: 206

Gabriela Vazquez Benitez

Favorite

6B-06 - Comparison of linked EHR-pharmacy dispensing data and health care claims during pregnancy
Location: 206

Gabriela Vazquez Benitez

Favorite

1D-06 - Preterm birth and small for gestational age following RSVpreF vaccination during pregnancy
Location: 208AB

Gabriela Vazquez Benitez

Favorite

1F-01 - Comparison of Lactation Information from Electronic Health Records with Survey Data Across Five US Health Systems
Location: 202AB

Gabriela Vazquez Benitez

Favorite

Venkataraman, Vidya

Truveta Inc.

3C-08 - Are heart failure diagnoses sufficient for heart failure classification? Evaluating NYHA class and ejection fraction extracted from unstructured EHR notes in improving heart failure classification using real-world data
Location: 201

Vidya Venkataraman

Favorite

Verhamme, Katia

Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC)

4A-04 - DARWIN EU® - Incidence of Erectile Dysfunction, Insomnia, and Hypertension in Incident Migraine and by Prophylactic Treatment initiation, Including CGRP Antagonists
Location: 207AB

Katia Verhamme

Favorite

5A-06 - DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics
Location: 208AB

Katia Verhamme

Favorite

1B-01 - DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe
Location: 206

Katia Verhamme

Favorite

Verpillat, Patrice

European Medicines Agency

Plenary: Pragmatic Pharmacoepidemiology: Innovative Clinical Evidence Supporting Regulatory Decision-making
Location: Ballroom AB

Patrice Verpillat

Favorite

SC-03 - Regulatory Pharmacoepidemiology
Location: 204ABC

Patrice Verpillat

Favorite

SW-1A - Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research
Location: 202AB

Patrice Verpillat

Favorite

SW-3B - Developing Computable Phenotypes for Medical Product Safety Surveillance: Innovative Methods and Data Sources
Location: 207AB

Patrice Verpillat

Favorite

Verweij, Stefan

University of Groningen

6E-03 - A Target Trial Emulation with an Extension to Subgroups: an Example for Relapsing-Remitting Multiple Sclerosis
Location: Ballroom AB

Stefan Verweij

Favorite

Vesco, Kimberly

Center for Health Research, Kaiser Permanente Northwest

1D-06 - Preterm birth and small for gestational age following RSVpreF vaccination during pregnancy
Location: 208AB

Kimberly Vesco

Favorite

Vetter, Joy

Optum Epidemiology

5C-06 - Incidence Rates of Myocarditis/Pericarditis after Pfizer-BioNTech COVID-19 Vaccine in the United States: Interim Results From a Postapproval Safety Study, Primary Series Analysis
Location: 204ABC

Joy Vetter

Favorite

Vickers-Smith, Rachel

UK College of Public Health

5A-04 - Changes in Gabapentin Prescription Fills Among Medicaid Enrollees Following State-Level Schedule V Controlled Substance Classification
Location: 208AB

Rachel Vickers-Smith

Favorite

Villalobos, Felipe

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain

Felipe Villalobos

Favorite

5C-03 - Evaluating the Safety Profile of the Janssen COVID-19 Vaccine (JCOVDEN): A VAC4EU post-authorization safety study
Location: 204ABC

Felipe Villalobos

Favorite

Vine, Seanna

Brigham and Women's Hospital and Harvard Medical School

3B-04 - Utilization Patterns of Anticoagulants Before, During, and After Pregnancy in the United States
Location: 204ABC

Seanna Vine

Favorite

1E-02 - Risk of Opioid Overdose Associated with Concurrent Use of Hydrocodone and CYP3A4-inhibiting Calcium Channel Blockers
Location: 204ABC

Seanna Vine

Favorite

1E-03 - Opioid Overdose Associated With Concomitant Use of Hydrocodone And Selective Serotonin Reuptake Inhibitors
Location: 204ABC

Seanna Vine

Favorite

1F-06 - Optimization of ICD-10-based algorithms for estimating gestational age for live and non-live births in healthcare databases
Location: 202AB

Seanna Vine

Favorite

Viprey, Marie

Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France

4C-05 - Impact of Cardiovascular Drug Shortages on Chronic Disease Patient Care in France between 2014 and 2019
Location: 206

Marie Viprey

Favorite

Virgili, Gianni

Department NEUROFARBA, University of Florence, Italy

3D-03 - An experiment from SeValid: Integration of Artificial Intelligence in the Clinical Validation Pipeline of the VACcine Monitoring Collaboration for Europe (VAC4EU)
Location: Ballroom AB

Gianni Virgili

Favorite

Virkud, Arti

University of Pennsylvania Center for Causal Inference

4A-01 - Clarifying Contradictions: Transportability Using Doubly Debiased Machine Learning in 17P Trials and Preterm Birth Outcomes
Location: 207AB

Arti Virkud

Favorite

Visaria, Aayush

Department of Medicine, Rutgers Robert Wood Johnson Medical School

5G-06 - Are Heat-Related Hospitalization Exacerbated by Heat-Sensitizing Medications in Older Adults ?
Location: 201

Aayush Visaria

Favorite

Vivirito, Annika

InGef Institute

2B-06 - Use of fluoroquinolones and the risk of seizures: a population-based cohort study
Location: 204ABC

Annika Vivirito

Favorite

Vojinovic, Dina

IQVIA, Real World Solutions, Amsterdam, The Netherlands

4A-04 - DARWIN EU® - Incidence of Erectile Dysfunction, Insomnia, and Hypertension in Incident Migraine and by Prophylactic Treatment initiation, Including CGRP Antagonists
Location: 207AB

Dina Vojinovic

Favorite

5A-06 - DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics
Location: 208AB

Dina Vojinovic

Favorite

Vojjala, Shiva

Carelon Research

6D-02 - Developing a Cancer Stage Model in Patients with Incident Colorectal Cancer Using Data from a Cancer Care Quality Program and Administrative Claims
Location: 201

Shiva Vojjala

Favorite

Vos, Robert O

University of Southern California, Spatial Sciences Institute

3C-11 - Trends and Disparities in Pharmacy Shortage Areas in Urban, Suburban,and Rural Neighborhoods in the U.S.
Location: 201

Robert O Vos

Favorite

Voss, Erica

Johnson & Johnson

3G-02 - Patterns of Topiramate Use Among Women of Childbearing Potential in the USA (2000-2023)
Location: 202AB

Erica Voss

Favorite

Vuković, Jakov

Croatia National Public Health Information System, Croatia

4A-04 - DARWIN EU® - Incidence of Erectile Dysfunction, Insomnia, and Hypertension in Incident Migraine and by Prophylactic Treatment initiation, Including CGRP Antagonists
Location: 207AB

Jakov Vuković

Favorite